Hemostemix (CVE:HEM) Trading Up 71.4% – What’s Next?
Hemostemix Inc. (CVE:HEM – Get Free Report)’s stock price shot up 71.4% during trading on Wednesday . The company traded as high as C$0.12 and last traded at C$0.12. 592,088 shares changed hands during mid-day trading, an increase of 516% from the average session volume of 96,162 shares. The stock had previously closed at C$0.07. […]
More Stories
Revance Therapeutics (NASDAQ:RVNC) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Sunday....
OptimumBank (NASDAQ:OPHC) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of OptimumBank (NASDAQ:OPHC – Free Report) in a research note published on Sunday morning. The...
Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report released on Sunday morning. The...
Avinger (NASDAQ:AVGR) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a report published on Sunday morning. The firm...
AppFolio (NASDAQ:APPF) Rating Lowered to Neutral at Piper Sandler
AppFolio (NASDAQ:APPF – Get Free Report) was downgraded by equities research analysts at Piper Sandler from an “overweight” rating to...
Ricky Sandler Sells 915,603 Shares of Entain Plc (LON:ENT) Stock
Entain Plc (LON:ENT – Get Free Report) insider Ricky Sandler sold 915,603 shares of the business’s stock in a transaction...